Breaking Research - Medika Life

CATEGORIES

Breaking Research

Why Healing Still Begins with Relationship

Gil Bashe, Medika Life Editor - February 1, 2026

AI in Public Health: Revolution, Risk and Opportunity

Christopher Nial - June 1, 2025

HPV Urban Legends – From Contagion to Symptoms to Risks to Prevention – There Are More Rare Concerns that Deserve Our Attention

Gil Bashe, Medika Life Editor - July 5, 2024

Researchers Have Stepped Into the Weird World of Science Fiction

Pat Farrell PhD - March 18, 2024

LATEST

Nutrition

Dairy Fats Reduce Your Risk of Heart Attack, New Study Finds

Medika Life - October 5, 2021

Editors Choice

Amount of Virus in Lungs Tied to Death from COVID-19

Dr. Hesham A. Hassaballa - September 1, 2021

Breaking Research

New Study Suggests Long-Lasting Immunity After COVID

Dr. Hesham A. Hassaballa - July 15, 2021

Healthcare Policy and Opinion

Central Dogma has Lost its Dog

Science Duuude - June 15, 2021

Neurological

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston - June 8, 2021

News and Views

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

James Coyne - June 2, 2021

Research Critique

The MDMA-Assisted Therapy for PTSD Study. What You’ll Get Wrong

James Coyne - May 25, 2021

Coronavirus

Texas Tech Professor Invents Game-Changing Ultra Rapid Covid-19 Sensor

Dr Jeff Livingston - May 16, 2021

Press Release

Research on Controlling Cellular Outposts of the Immune System

Medika Life - May 12, 2021

1 23Page 3 of 3

TRENDING

Were the Billions Invested in Alzheimer’s Research Worthwhile?

Gil Bashe, Medika Life Editor - January 18, 2022

Pursuing Happy Modernity: AI and Human Exploration in New Research-Based Tech

Atefeh Ferdosipour - January 7, 2024

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston - June 8, 2021

Texas Tech Professor Invents Game-Changing Ultra Rapid Covid-19 Sensor

Dr Jeff Livingston - May 16, 2021

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

James Coyne - June 2, 2021

Central Dogma has Lost its Dog

Science Duuude - June 15, 2021

Aiding and Abetting a Virus

Richard Hatzfeld - February 21, 2022

Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T

William Haseltine, PhD - April 16, 2023

Breakthrough Infections Dramatically Enhance COVID Immunity

Dr. Hesham A. Hassaballa - December 16, 2021

Perhaps, A Braver New World

John Nosta - December 27, 2021

EDITORS CHOICE

Pursuing Happy Modernity: AI and Human Exploration in New Research-Based Tech

Atefeh Ferdosipour - January 7, 2024

2024, it will be subject to the qualitative and quantitative changes in artificial intelligence.

Amount of Virus in Lungs Tied to Death from COVID-19

Dr. Hesham A. Hassaballa - September 1, 2021

It has happened to me and my colleagues far too often: watching a patient die from complications of COVID-19. While the ultimate cause of...

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

James Coyne - June 2, 2021

The largest number of authors (12) are with MAPS. The for-profit corporation will manage sales for prescription MDMA when it is approved by the FDA

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston - June 8, 2021

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories